Skip to main content
Clinical Trials/ITMCTR2200006126
ITMCTR2200006126
Not yet recruiting
Phase 1

Optimization of diagnosis and treatment plan for idiopathic membranous nephropathy in the integrative medicine

Shanxi Hospital of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Idiopathic Membranous Nephropathy
Sponsor
Shanxi Hospital of Traditional Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Shanxi Hospital of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • ( 1 ) Patients with idiopathic membranous nephropathy ( IMN ) nephrotic syndrome confirmed by renal biopsy and clinical examination were pathologically divided into stages I to II ;
  • ( 2 ) Age in 18\-75 years old, gender, ethnic limit ;
  • ( 3 ) signing informed consent ;
  • ( 4 ) TCM syndromes are qi deficiency and blood stasis or damp heat and blood stasis ;
  • ( 4 ) 24\-hour urinary protein excretion \> 3\.5g / 24h
  • ( 5 ) Serum creatinine \= 133umol / L or endogenous creatinine clearance rate 60ml / min / 1\.73m2 was included in the study.

Exclusion Criteria

  • ( 1 ) Pregnancy or lactation patients ;
  • ( 2 ) Complicated with severe primary diseases such as decompensated cirrhosis, active malignant tumor or hematopoietic system ;
  • ( 3 ) Those with acute myocardial infarction, cerebral infarction or cerebral hemorrhage in the first three months were included ;
  • ( 4 ) Severe arrhythmia, severe heart failure, NYHA class III or above ;
  • ( 5 ) Patients with severe infectious diseases when included ;
  • ( 6 ) Patients with clear thrombosis were included ;
  • ( 7 ) During the treatment period, the patients with natural loss or loss of follow\-up, poor compliance and discontinued or not taking medicine, there are serious adverse events, serious other patients with onset or deterioration.

Outcomes

Primary Outcomes

Not specified

Similar Trials